Global Hemoperfusion Market Growth 2026-2032
The global Hemoperfusion market size is predicted to grow from US$ 468 million in 2025 to US$ 810 million in 2032; it is expected to grow at a CAGR of 8.9% from 2026 to 2032.
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.In 2025, global Hemoperfusion production reached approximately 7052 K Unit.
Hemoperfusion demand is driven first by clinical need in critical care where standard supportive therapies (ventilation, vasopressors, renal replacement therapy) don’t directly remove circulating toxins or inflammatory mediators. The core use-cases that pull adoption are: acute poisonings/drug intoxications (where removing protein-bound or lipophilic toxins can matter), liver failure and hyperbilirubinemia, and severe systemic inflammation (sepsis/septic shock, pancreatitis, certain post-surgical or trauma inflammatory states) where clinicians aim to reduce circulating cytokines/endotoxin burden. Growth is also supported by rising ICU volumes tied to aging populations and higher prevalence of multi-morbidity (cardiometabolic disease, chronic kidney disease), plus increasing recognition of “adjunctive blood purification” options in settings where mortality remains high despite best-practice bundles.
A second set of drivers is workflow and technology fit: hemoperfusion can be deployed as a stand-alone circuit or integrated with CRRT/ECMO platforms, allowing hospitals to add it without building an entirely new infrastructure. The market is pulled by single-use consumables (cartridges/columns) with predictable ordering patterns once protocols are established, and by product improvements such as higher adsorption capacity, better biocompatibility, lower clotting risk, and more consistent performance across patient conditions. Commercial adoption is strongly influenced by reimbursement coverage, local health-technology assessments, and hospital procurement economics (ICU length-of-stay impact, vasopressor days, dialysis days). Finally, evidence quality is a major gatekeeper: more positive real-world data, better patient-selection criteria, and clearer endpoints (hemodynamic stabilization, organ-support intensity, biomarker kinetics) tend to unlock broader uptake, while mixed trial outcomes can slow it or confine usage to specific indications and regions.
Gross profit margin (industry, short): hemoperfusion is typically a high–gross-margin consumables model (single-use cartridges plus accessories) once scale and yields are stable, because material costs are modest relative to clinical selling price and value is tied to outcomes and compatibility. In practice, margins vary widely by region and competitive intensity, but many established players target roughly ~50–70% gross margin.
LP Information, Inc. (LPI) ' newest research report, the “Hemoperfusion Industry Forecast” looks at past sales and reviews total world Hemoperfusion sales in 2025, providing a comprehensive analysis by region and market sector of projected Hemoperfusion sales for 2026 through 2032. With Hemoperfusion sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemoperfusion industry.
This Insight Report provides a comprehensive analysis of the global Hemoperfusion landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemoperfusion portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hemoperfusion market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemoperfusion and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemoperfusion.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemoperfusion market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Hemoperfusion market?
What factors are driving Hemoperfusion market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hemoperfusion market opportunities vary by end market size?
How does Hemoperfusion break out by Type, by Application?
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.In 2025, global Hemoperfusion production reached approximately 7052 K Unit.
Hemoperfusion demand is driven first by clinical need in critical care where standard supportive therapies (ventilation, vasopressors, renal replacement therapy) don’t directly remove circulating toxins or inflammatory mediators. The core use-cases that pull adoption are: acute poisonings/drug intoxications (where removing protein-bound or lipophilic toxins can matter), liver failure and hyperbilirubinemia, and severe systemic inflammation (sepsis/septic shock, pancreatitis, certain post-surgical or trauma inflammatory states) where clinicians aim to reduce circulating cytokines/endotoxin burden. Growth is also supported by rising ICU volumes tied to aging populations and higher prevalence of multi-morbidity (cardiometabolic disease, chronic kidney disease), plus increasing recognition of “adjunctive blood purification” options in settings where mortality remains high despite best-practice bundles.
A second set of drivers is workflow and technology fit: hemoperfusion can be deployed as a stand-alone circuit or integrated with CRRT/ECMO platforms, allowing hospitals to add it without building an entirely new infrastructure. The market is pulled by single-use consumables (cartridges/columns) with predictable ordering patterns once protocols are established, and by product improvements such as higher adsorption capacity, better biocompatibility, lower clotting risk, and more consistent performance across patient conditions. Commercial adoption is strongly influenced by reimbursement coverage, local health-technology assessments, and hospital procurement economics (ICU length-of-stay impact, vasopressor days, dialysis days). Finally, evidence quality is a major gatekeeper: more positive real-world data, better patient-selection criteria, and clearer endpoints (hemodynamic stabilization, organ-support intensity, biomarker kinetics) tend to unlock broader uptake, while mixed trial outcomes can slow it or confine usage to specific indications and regions.
Gross profit margin (industry, short): hemoperfusion is typically a high–gross-margin consumables model (single-use cartridges plus accessories) once scale and yields are stable, because material costs are modest relative to clinical selling price and value is tied to outcomes and compatibility. In practice, margins vary widely by region and competitive intensity, but many established players target roughly ~50–70% gross margin.
LP Information, Inc. (LPI) ' newest research report, the “Hemoperfusion Industry Forecast” looks at past sales and reviews total world Hemoperfusion sales in 2025, providing a comprehensive analysis by region and market sector of projected Hemoperfusion sales for 2026 through 2032. With Hemoperfusion sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemoperfusion industry.
This Insight Report provides a comprehensive analysis of the global Hemoperfusion landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemoperfusion portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hemoperfusion market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemoperfusion and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemoperfusion.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemoperfusion market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Activated Carbon Adsorption
- Resin Adsorption
- Plasma Perfusion
- Whole Blood Perfusion
- Direct Selling
- Distribution
- Hepatic Encephalopathy
- Certain Autoimmune Diseases
- Drug Overdose
- Specific Intoxications
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Jianfan Biotech
- Kangbei Medical
- Foshan Boxin (Lily Medical)
- Baxter
- Asahi Kasei
What is the 10-year outlook for the global Hemoperfusion market?
What factors are driving Hemoperfusion market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hemoperfusion market opportunities vary by end market size?
How does Hemoperfusion break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hemoperfusion Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Hemoperfusion by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Hemoperfusion by Country/Region, 2021, 2025 & 2032
2.2 Hemoperfusion Segment by Type
2.2.1 Activated Carbon Adsorption
2.2.2 Resin Adsorption
2.2.3 Hemoperfusion Sales by Type
2.2.3.1 Global Hemoperfusion Sales Market Share by Type (2021-2026)
2.2.3.2 Global Hemoperfusion Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Hemoperfusion Sale Price by Type (2021-2026)
2.3 Hemoperfusion Segment by Feature
2.3.1 Plasma Perfusion
2.3.2 Whole Blood Perfusion
2.3.3 Hemoperfusion Sales by Feature
2.3.3.1 Global Hemoperfusion Sales Market Share by Feature (2021-2026)
2.3.3.2 Global Hemoperfusion Revenue and Market Share by Feature (2021-2026)
2.3.3.3 Global Hemoperfusion Sale Price by Feature (2021-2026)
2.4 Hemoperfusion Segment by Channel
2.4.1 Direct Selling
2.4.2 Distribution
2.4.3 Hemoperfusion Sales by Channel
2.4.3.1 Global Hemoperfusion Sales Market Share by Channel (2021-2026)
2.4.3.2 Global Hemoperfusion Revenue and Market Share by Channel (2021-2026)
2.4.3.3 Global Hemoperfusion Sale Price by Channel (2021-2026)
2.5 Hemoperfusion Segment by Application
2.5.1 Hepatic Encephalopathy
2.5.2 Certain Autoimmune Diseases
2.5.3 Drug Overdose
2.5.4 Specific Intoxications
2.5.5 Others
2.5.6 Hemoperfusion Sales by Application
2.5.6.1 Global Hemoperfusion Sale Market Share by Application (2021-2026)
2.5.6.2 Global Hemoperfusion Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Hemoperfusion Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Hemoperfusion Breakdown Data by Company
3.1.1 Global Hemoperfusion Annual Sales by Company (2021-2026)
3.1.2 Global Hemoperfusion Sales Market Share by Company (2021-2026)
3.2 Global Hemoperfusion Annual Revenue by Company (2021-2026)
3.2.1 Global Hemoperfusion Revenue by Company (2021-2026)
3.2.2 Global Hemoperfusion Revenue Market Share by Company (2021-2026)
3.3 Global Hemoperfusion Sale Price by Company
3.4 Key Manufacturers Hemoperfusion Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hemoperfusion Product Location Distribution
3.4.2 Players Hemoperfusion Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HEMOPERFUSION BY GEOGRAPHIC REGION
4.1 World Historic Hemoperfusion Market Size by Geographic Region (2021-2026)
4.1.1 Global Hemoperfusion Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Hemoperfusion Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Hemoperfusion Market Size by Country/Region (2021-2026)
4.2.1 Global Hemoperfusion Annual Sales by Country/Region (2021-2026)
4.2.2 Global Hemoperfusion Annual Revenue by Country/Region (2021-2026)
4.3 Americas Hemoperfusion Sales Growth
4.4 APAC Hemoperfusion Sales Growth
4.5 Europe Hemoperfusion Sales Growth
4.6 Middle East & Africa Hemoperfusion Sales Growth
5 AMERICAS
5.1 Americas Hemoperfusion Sales by Country
5.1.1 Americas Hemoperfusion Sales by Country (2021-2026)
5.1.2 Americas Hemoperfusion Revenue by Country (2021-2026)
5.2 Americas Hemoperfusion Sales by Type (2021-2026)
5.3 Americas Hemoperfusion Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemoperfusion Sales by Region
6.1.1 APAC Hemoperfusion Sales by Region (2021-2026)
6.1.2 APAC Hemoperfusion Revenue by Region (2021-2026)
6.2 APAC Hemoperfusion Sales by Type (2021-2026)
6.3 APAC Hemoperfusion Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hemoperfusion by Country
7.1.1 Europe Hemoperfusion Sales by Country (2021-2026)
7.1.2 Europe Hemoperfusion Revenue by Country (2021-2026)
7.2 Europe Hemoperfusion Sales by Type (2021-2026)
7.3 Europe Hemoperfusion Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hemoperfusion by Country
8.1.1 Middle East & Africa Hemoperfusion Sales by Country (2021-2026)
8.1.2 Middle East & Africa Hemoperfusion Revenue by Country (2021-2026)
8.2 Middle East & Africa Hemoperfusion Sales by Type (2021-2026)
8.3 Middle East & Africa Hemoperfusion Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hemoperfusion
10.3 Manufacturing Process Analysis of Hemoperfusion
10.4 Industry Chain Structure of Hemoperfusion
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hemoperfusion Distributors
11.3 Hemoperfusion Customer
12 WORLD FORECAST REVIEW FOR HEMOPERFUSION BY GEOGRAPHIC REGION
12.1 Global Hemoperfusion Market Size Forecast by Region
12.1.1 Global Hemoperfusion Forecast by Region (2027-2032)
12.1.2 Global Hemoperfusion Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Hemoperfusion Forecast by Type (2027-2032)
12.7 Global Hemoperfusion Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jianfan Biotech
13.1.1 Jianfan Biotech Company Information
13.1.2 Jianfan Biotech Hemoperfusion Product Portfolios and Specifications
13.1.3 Jianfan Biotech Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jianfan Biotech Main Business Overview
13.1.5 Jianfan Biotech Latest Developments
13.2 Kangbei Medical
13.2.1 Kangbei Medical Company Information
13.2.2 Kangbei Medical Hemoperfusion Product Portfolios and Specifications
13.2.3 Kangbei Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Kangbei Medical Main Business Overview
13.2.5 Kangbei Medical Latest Developments
13.3 Foshan Boxin (Lily Medical)
13.3.1 Foshan Boxin (Lily Medical) Company Information
13.3.2 Foshan Boxin (Lily Medical) Hemoperfusion Product Portfolios and Specifications
13.3.3 Foshan Boxin (Lily Medical) Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Foshan Boxin (Lily Medical) Main Business Overview
13.3.5 Foshan Boxin (Lily Medical) Latest Developments
13.4 Baxter
13.4.1 Baxter Company Information
13.4.2 Baxter Hemoperfusion Product Portfolios and Specifications
13.4.3 Baxter Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Baxter Main Business Overview
13.4.5 Baxter Latest Developments
13.5 Asahi Kasei
13.5.1 Asahi Kasei Company Information
13.5.2 Asahi Kasei Hemoperfusion Product Portfolios and Specifications
13.5.3 Asahi Kasei Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Asahi Kasei Main Business Overview
13.5.5 Asahi Kasei Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hemoperfusion Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Hemoperfusion by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Hemoperfusion by Country/Region, 2021, 2025 & 2032
2.2 Hemoperfusion Segment by Type
2.2.1 Activated Carbon Adsorption
2.2.2 Resin Adsorption
2.2.3 Hemoperfusion Sales by Type
2.2.3.1 Global Hemoperfusion Sales Market Share by Type (2021-2026)
2.2.3.2 Global Hemoperfusion Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Hemoperfusion Sale Price by Type (2021-2026)
2.3 Hemoperfusion Segment by Feature
2.3.1 Plasma Perfusion
2.3.2 Whole Blood Perfusion
2.3.3 Hemoperfusion Sales by Feature
2.3.3.1 Global Hemoperfusion Sales Market Share by Feature (2021-2026)
2.3.3.2 Global Hemoperfusion Revenue and Market Share by Feature (2021-2026)
2.3.3.3 Global Hemoperfusion Sale Price by Feature (2021-2026)
2.4 Hemoperfusion Segment by Channel
2.4.1 Direct Selling
2.4.2 Distribution
2.4.3 Hemoperfusion Sales by Channel
2.4.3.1 Global Hemoperfusion Sales Market Share by Channel (2021-2026)
2.4.3.2 Global Hemoperfusion Revenue and Market Share by Channel (2021-2026)
2.4.3.3 Global Hemoperfusion Sale Price by Channel (2021-2026)
2.5 Hemoperfusion Segment by Application
2.5.1 Hepatic Encephalopathy
2.5.2 Certain Autoimmune Diseases
2.5.3 Drug Overdose
2.5.4 Specific Intoxications
2.5.5 Others
2.5.6 Hemoperfusion Sales by Application
2.5.6.1 Global Hemoperfusion Sale Market Share by Application (2021-2026)
2.5.6.2 Global Hemoperfusion Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Hemoperfusion Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Hemoperfusion Breakdown Data by Company
3.1.1 Global Hemoperfusion Annual Sales by Company (2021-2026)
3.1.2 Global Hemoperfusion Sales Market Share by Company (2021-2026)
3.2 Global Hemoperfusion Annual Revenue by Company (2021-2026)
3.2.1 Global Hemoperfusion Revenue by Company (2021-2026)
3.2.2 Global Hemoperfusion Revenue Market Share by Company (2021-2026)
3.3 Global Hemoperfusion Sale Price by Company
3.4 Key Manufacturers Hemoperfusion Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hemoperfusion Product Location Distribution
3.4.2 Players Hemoperfusion Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HEMOPERFUSION BY GEOGRAPHIC REGION
4.1 World Historic Hemoperfusion Market Size by Geographic Region (2021-2026)
4.1.1 Global Hemoperfusion Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Hemoperfusion Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Hemoperfusion Market Size by Country/Region (2021-2026)
4.2.1 Global Hemoperfusion Annual Sales by Country/Region (2021-2026)
4.2.2 Global Hemoperfusion Annual Revenue by Country/Region (2021-2026)
4.3 Americas Hemoperfusion Sales Growth
4.4 APAC Hemoperfusion Sales Growth
4.5 Europe Hemoperfusion Sales Growth
4.6 Middle East & Africa Hemoperfusion Sales Growth
5 AMERICAS
5.1 Americas Hemoperfusion Sales by Country
5.1.1 Americas Hemoperfusion Sales by Country (2021-2026)
5.1.2 Americas Hemoperfusion Revenue by Country (2021-2026)
5.2 Americas Hemoperfusion Sales by Type (2021-2026)
5.3 Americas Hemoperfusion Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemoperfusion Sales by Region
6.1.1 APAC Hemoperfusion Sales by Region (2021-2026)
6.1.2 APAC Hemoperfusion Revenue by Region (2021-2026)
6.2 APAC Hemoperfusion Sales by Type (2021-2026)
6.3 APAC Hemoperfusion Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hemoperfusion by Country
7.1.1 Europe Hemoperfusion Sales by Country (2021-2026)
7.1.2 Europe Hemoperfusion Revenue by Country (2021-2026)
7.2 Europe Hemoperfusion Sales by Type (2021-2026)
7.3 Europe Hemoperfusion Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hemoperfusion by Country
8.1.1 Middle East & Africa Hemoperfusion Sales by Country (2021-2026)
8.1.2 Middle East & Africa Hemoperfusion Revenue by Country (2021-2026)
8.2 Middle East & Africa Hemoperfusion Sales by Type (2021-2026)
8.3 Middle East & Africa Hemoperfusion Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hemoperfusion
10.3 Manufacturing Process Analysis of Hemoperfusion
10.4 Industry Chain Structure of Hemoperfusion
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hemoperfusion Distributors
11.3 Hemoperfusion Customer
12 WORLD FORECAST REVIEW FOR HEMOPERFUSION BY GEOGRAPHIC REGION
12.1 Global Hemoperfusion Market Size Forecast by Region
12.1.1 Global Hemoperfusion Forecast by Region (2027-2032)
12.1.2 Global Hemoperfusion Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Hemoperfusion Forecast by Type (2027-2032)
12.7 Global Hemoperfusion Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jianfan Biotech
13.1.1 Jianfan Biotech Company Information
13.1.2 Jianfan Biotech Hemoperfusion Product Portfolios and Specifications
13.1.3 Jianfan Biotech Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jianfan Biotech Main Business Overview
13.1.5 Jianfan Biotech Latest Developments
13.2 Kangbei Medical
13.2.1 Kangbei Medical Company Information
13.2.2 Kangbei Medical Hemoperfusion Product Portfolios and Specifications
13.2.3 Kangbei Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Kangbei Medical Main Business Overview
13.2.5 Kangbei Medical Latest Developments
13.3 Foshan Boxin (Lily Medical)
13.3.1 Foshan Boxin (Lily Medical) Company Information
13.3.2 Foshan Boxin (Lily Medical) Hemoperfusion Product Portfolios and Specifications
13.3.3 Foshan Boxin (Lily Medical) Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Foshan Boxin (Lily Medical) Main Business Overview
13.3.5 Foshan Boxin (Lily Medical) Latest Developments
13.4 Baxter
13.4.1 Baxter Company Information
13.4.2 Baxter Hemoperfusion Product Portfolios and Specifications
13.4.3 Baxter Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Baxter Main Business Overview
13.4.5 Baxter Latest Developments
13.5 Asahi Kasei
13.5.1 Asahi Kasei Company Information
13.5.2 Asahi Kasei Hemoperfusion Product Portfolios and Specifications
13.5.3 Asahi Kasei Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Asahi Kasei Main Business Overview
13.5.5 Asahi Kasei Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hemoperfusion Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Hemoperfusion Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Activated Carbon Adsorption
Table 4. Major Players of Resin Adsorption
Table 5. Global Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 6. Global Hemoperfusion Sales Market Share by Type (2021-2026)
Table 7. Global Hemoperfusion Revenue by Type (2021-2026) & ($ million)
Table 8. Global Hemoperfusion Revenue Market Share by Type (2021-2026)
Table 9. Global Hemoperfusion Sale Price by Type (2021-2026) & (USD/Unit)
Table 10. Major Players of Plasma Perfusion
Table 11. Major Players of Whole Blood Perfusion
Table 12. Global Hemoperfusion Sales by Feature (2021-2026) & (K Units)
Table 13. Global Hemoperfusion Sales Market Share by Feature (2021-2026)
Table 14. Global Hemoperfusion Revenue by Feature (2021-2026) & ($ million)
Table 15. Global Hemoperfusion Revenue Market Share by Feature (2021-2026)
Table 16. Global Hemoperfusion Sale Price by Feature (2021-2026) & (USD/Unit)
Table 17. Major Players of Direct Selling
Table 18. Major Players of Distribution
Table 19. Global Hemoperfusion Sales by Channel (2021-2026) & (K Units)
Table 20. Global Hemoperfusion Sales Market Share by Channel (2021-2026)
Table 21. Global Hemoperfusion Revenue by Channel (2021-2026) & ($ million)
Table 22. Global Hemoperfusion Revenue Market Share by Channel (2021-2026)
Table 23. Global Hemoperfusion Sale Price by Channel (2021-2026) & (USD/Unit)
Table 24. Global Hemoperfusion Sale by Application (2021-2026) & (K Units)
Table 25. Global Hemoperfusion Sale Market Share by Application (2021-2026)
Table 26. Global Hemoperfusion Revenue by Application (2021-2026) & ($ million)
Table 27. Global Hemoperfusion Revenue Market Share by Application (2021-2026)
Table 28. Global Hemoperfusion Sale Price by Application (2021-2026) & (USD/Unit)
Table 29. Global Hemoperfusion Sales by Company (2021-2026) & (K Units)
Table 30. Global Hemoperfusion Sales Market Share by Company (2021-2026)
Table 31. Global Hemoperfusion Revenue by Company (2021-2026) & ($ millions)
Table 32. Global Hemoperfusion Revenue Market Share by Company (2021-2026)
Table 33. Global Hemoperfusion Sale Price by Company (2021-2026) & (USD/Unit)
Table 34. Key Manufacturers Hemoperfusion Producing Area Distribution and Sales Area
Table 35. Players Hemoperfusion Products Offered
Table 36. Hemoperfusion Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 37. New Products and Potential Entrants
Table 38. Market M&A Activity & Strategy
Table 39. Global Hemoperfusion Sales by Geographic Region (2021-2026) & (K Units)
Table 40. Global Hemoperfusion Sales Market Share Geographic Region (2021-2026)
Table 41. Global Hemoperfusion Revenue by Geographic Region (2021-2026) & ($ millions)
Table 42. Global Hemoperfusion Revenue Market Share by Geographic Region (2021-2026)
Table 43. Global Hemoperfusion Sales by Country/Region (2021-2026) & (K Units)
Table 44. Global Hemoperfusion Sales Market Share by Country/Region (2021-2026)
Table 45. Global Hemoperfusion Revenue by Country/Region (2021-2026) & ($ millions)
Table 46. Global Hemoperfusion Revenue Market Share by Country/Region (2021-2026)
Table 47. Americas Hemoperfusion Sales by Country (2021-2026) & (K Units)
Table 48. Americas Hemoperfusion Sales Market Share by Country (2021-2026)
Table 49. Americas Hemoperfusion Revenue by Country (2021-2026) & ($ millions)
Table 50. Americas Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 51. Americas Hemoperfusion Sales by Application (2021-2026) & (K Units)
Table 52. APAC Hemoperfusion Sales by Region (2021-2026) & (K Units)
Table 53. APAC Hemoperfusion Sales Market Share by Region (2021-2026)
Table 54. APAC Hemoperfusion Revenue by Region (2021-2026) & ($ millions)
Table 55. APAC Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 56. APAC Hemoperfusion Sales by Application (2021-2026) & (K Units)
Table 57. Europe Hemoperfusion Sales by Country (2021-2026) & (K Units)
Table 58. Europe Hemoperfusion Revenue by Country (2021-2026) & ($ millions)
Table 59. Europe Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 60. Europe Hemoperfusion Sales by Application (2021-2026) & (K Units)
Table 61. Middle East & Africa Hemoperfusion Sales by Country (2021-2026) & (K Units)
Table 62. Middle East & Africa Hemoperfusion Revenue Market Share by Country (2021-2026)
Table 63. Middle East & Africa Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 64. Middle East & Africa Hemoperfusion Sales by Application (2021-2026) & (K Units)
Table 65. Key Market Drivers & Growth Opportunities of Hemoperfusion
Table 66. Key Market Challenges & Risks of Hemoperfusion
Table 67. Key Industry Trends of Hemoperfusion
Table 68. Hemoperfusion Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Hemoperfusion Distributors List
Table 71. Hemoperfusion Customer List
Table 72. Global Hemoperfusion Sales Forecast by Region (2027-2032) & (K Units)
Table 73. Global Hemoperfusion Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Americas Hemoperfusion Sales Forecast by Country (2027-2032) & (K Units)
Table 75. Americas Hemoperfusion Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. APAC Hemoperfusion Sales Forecast by Region (2027-2032) & (K Units)
Table 77. APAC Hemoperfusion Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Europe Hemoperfusion Sales Forecast by Country (2027-2032) & (K Units)
Table 79. Europe Hemoperfusion Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. Middle East & Africa Hemoperfusion Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Middle East & Africa Hemoperfusion Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Global Hemoperfusion Sales Forecast by Type (2027-2032) & (K Units)
Table 83. Global Hemoperfusion Revenue Forecast by Type (2027-2032) & ($ millions)
Table 84. Global Hemoperfusion Sales Forecast by Application (2027-2032) & (K Units)
Table 85. Global Hemoperfusion Revenue Forecast by Application (2027-2032) & ($ millions)
Table 86. Jianfan Biotech Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 87. Jianfan Biotech Hemoperfusion Product Portfolios and Specifications
Table 88. Jianfan Biotech Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 89. Jianfan Biotech Main Business
Table 90. Jianfan Biotech Latest Developments
Table 91. Kangbei Medical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 92. Kangbei Medical Hemoperfusion Product Portfolios and Specifications
Table 93. Kangbei Medical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 94. Kangbei Medical Main Business
Table 95. Kangbei Medical Latest Developments
Table 96. Foshan Boxin (Lily Medical) Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 97. Foshan Boxin (Lily Medical) Hemoperfusion Product Portfolios and Specifications
Table 98. Foshan Boxin (Lily Medical) Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 99. Foshan Boxin (Lily Medical) Main Business
Table 100. Foshan Boxin (Lily Medical) Latest Developments
Table 101. Baxter Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 102. Baxter Hemoperfusion Product Portfolios and Specifications
Table 103. Baxter Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 104. Baxter Main Business
Table 105. Baxter Latest Developments
Table 106. Asahi Kasei Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 107. Asahi Kasei Hemoperfusion Product Portfolios and Specifications
Table 108. Asahi Kasei Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 109. Asahi Kasei Main Business
Table 110. Asahi Kasei Latest Developments
Table 1. Hemoperfusion Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Hemoperfusion Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Activated Carbon Adsorption
Table 4. Major Players of Resin Adsorption
Table 5. Global Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 6. Global Hemoperfusion Sales Market Share by Type (2021-2026)
Table 7. Global Hemoperfusion Revenue by Type (2021-2026) & ($ million)
Table 8. Global Hemoperfusion Revenue Market Share by Type (2021-2026)
Table 9. Global Hemoperfusion Sale Price by Type (2021-2026) & (USD/Unit)
Table 10. Major Players of Plasma Perfusion
Table 11. Major Players of Whole Blood Perfusion
Table 12. Global Hemoperfusion Sales by Feature (2021-2026) & (K Units)
Table 13. Global Hemoperfusion Sales Market Share by Feature (2021-2026)
Table 14. Global Hemoperfusion Revenue by Feature (2021-2026) & ($ million)
Table 15. Global Hemoperfusion Revenue Market Share by Feature (2021-2026)
Table 16. Global Hemoperfusion Sale Price by Feature (2021-2026) & (USD/Unit)
Table 17. Major Players of Direct Selling
Table 18. Major Players of Distribution
Table 19. Global Hemoperfusion Sales by Channel (2021-2026) & (K Units)
Table 20. Global Hemoperfusion Sales Market Share by Channel (2021-2026)
Table 21. Global Hemoperfusion Revenue by Channel (2021-2026) & ($ million)
Table 22. Global Hemoperfusion Revenue Market Share by Channel (2021-2026)
Table 23. Global Hemoperfusion Sale Price by Channel (2021-2026) & (USD/Unit)
Table 24. Global Hemoperfusion Sale by Application (2021-2026) & (K Units)
Table 25. Global Hemoperfusion Sale Market Share by Application (2021-2026)
Table 26. Global Hemoperfusion Revenue by Application (2021-2026) & ($ million)
Table 27. Global Hemoperfusion Revenue Market Share by Application (2021-2026)
Table 28. Global Hemoperfusion Sale Price by Application (2021-2026) & (USD/Unit)
Table 29. Global Hemoperfusion Sales by Company (2021-2026) & (K Units)
Table 30. Global Hemoperfusion Sales Market Share by Company (2021-2026)
Table 31. Global Hemoperfusion Revenue by Company (2021-2026) & ($ millions)
Table 32. Global Hemoperfusion Revenue Market Share by Company (2021-2026)
Table 33. Global Hemoperfusion Sale Price by Company (2021-2026) & (USD/Unit)
Table 34. Key Manufacturers Hemoperfusion Producing Area Distribution and Sales Area
Table 35. Players Hemoperfusion Products Offered
Table 36. Hemoperfusion Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 37. New Products and Potential Entrants
Table 38. Market M&A Activity & Strategy
Table 39. Global Hemoperfusion Sales by Geographic Region (2021-2026) & (K Units)
Table 40. Global Hemoperfusion Sales Market Share Geographic Region (2021-2026)
Table 41. Global Hemoperfusion Revenue by Geographic Region (2021-2026) & ($ millions)
Table 42. Global Hemoperfusion Revenue Market Share by Geographic Region (2021-2026)
Table 43. Global Hemoperfusion Sales by Country/Region (2021-2026) & (K Units)
Table 44. Global Hemoperfusion Sales Market Share by Country/Region (2021-2026)
Table 45. Global Hemoperfusion Revenue by Country/Region (2021-2026) & ($ millions)
Table 46. Global Hemoperfusion Revenue Market Share by Country/Region (2021-2026)
Table 47. Americas Hemoperfusion Sales by Country (2021-2026) & (K Units)
Table 48. Americas Hemoperfusion Sales Market Share by Country (2021-2026)
Table 49. Americas Hemoperfusion Revenue by Country (2021-2026) & ($ millions)
Table 50. Americas Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 51. Americas Hemoperfusion Sales by Application (2021-2026) & (K Units)
Table 52. APAC Hemoperfusion Sales by Region (2021-2026) & (K Units)
Table 53. APAC Hemoperfusion Sales Market Share by Region (2021-2026)
Table 54. APAC Hemoperfusion Revenue by Region (2021-2026) & ($ millions)
Table 55. APAC Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 56. APAC Hemoperfusion Sales by Application (2021-2026) & (K Units)
Table 57. Europe Hemoperfusion Sales by Country (2021-2026) & (K Units)
Table 58. Europe Hemoperfusion Revenue by Country (2021-2026) & ($ millions)
Table 59. Europe Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 60. Europe Hemoperfusion Sales by Application (2021-2026) & (K Units)
Table 61. Middle East & Africa Hemoperfusion Sales by Country (2021-2026) & (K Units)
Table 62. Middle East & Africa Hemoperfusion Revenue Market Share by Country (2021-2026)
Table 63. Middle East & Africa Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 64. Middle East & Africa Hemoperfusion Sales by Application (2021-2026) & (K Units)
Table 65. Key Market Drivers & Growth Opportunities of Hemoperfusion
Table 66. Key Market Challenges & Risks of Hemoperfusion
Table 67. Key Industry Trends of Hemoperfusion
Table 68. Hemoperfusion Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Hemoperfusion Distributors List
Table 71. Hemoperfusion Customer List
Table 72. Global Hemoperfusion Sales Forecast by Region (2027-2032) & (K Units)
Table 73. Global Hemoperfusion Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Americas Hemoperfusion Sales Forecast by Country (2027-2032) & (K Units)
Table 75. Americas Hemoperfusion Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. APAC Hemoperfusion Sales Forecast by Region (2027-2032) & (K Units)
Table 77. APAC Hemoperfusion Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Europe Hemoperfusion Sales Forecast by Country (2027-2032) & (K Units)
Table 79. Europe Hemoperfusion Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. Middle East & Africa Hemoperfusion Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Middle East & Africa Hemoperfusion Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Global Hemoperfusion Sales Forecast by Type (2027-2032) & (K Units)
Table 83. Global Hemoperfusion Revenue Forecast by Type (2027-2032) & ($ millions)
Table 84. Global Hemoperfusion Sales Forecast by Application (2027-2032) & (K Units)
Table 85. Global Hemoperfusion Revenue Forecast by Application (2027-2032) & ($ millions)
Table 86. Jianfan Biotech Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 87. Jianfan Biotech Hemoperfusion Product Portfolios and Specifications
Table 88. Jianfan Biotech Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 89. Jianfan Biotech Main Business
Table 90. Jianfan Biotech Latest Developments
Table 91. Kangbei Medical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 92. Kangbei Medical Hemoperfusion Product Portfolios and Specifications
Table 93. Kangbei Medical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 94. Kangbei Medical Main Business
Table 95. Kangbei Medical Latest Developments
Table 96. Foshan Boxin (Lily Medical) Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 97. Foshan Boxin (Lily Medical) Hemoperfusion Product Portfolios and Specifications
Table 98. Foshan Boxin (Lily Medical) Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 99. Foshan Boxin (Lily Medical) Main Business
Table 100. Foshan Boxin (Lily Medical) Latest Developments
Table 101. Baxter Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 102. Baxter Hemoperfusion Product Portfolios and Specifications
Table 103. Baxter Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 104. Baxter Main Business
Table 105. Baxter Latest Developments
Table 106. Asahi Kasei Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 107. Asahi Kasei Hemoperfusion Product Portfolios and Specifications
Table 108. Asahi Kasei Hemoperfusion Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 109. Asahi Kasei Main Business
Table 110. Asahi Kasei Latest Developments
LIST OF FIGURES
Figure 1. Picture of Hemoperfusion
Figure 2. Hemoperfusion Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hemoperfusion Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Hemoperfusion Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Hemoperfusion Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Hemoperfusion Sales Market Share by Country/Region (2025)
Figure 10. Hemoperfusion Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Activated Carbon Adsorption
Figure 12. Product Picture of Resin Adsorption
Figure 13. Global Hemoperfusion Sales Market Share by Type in 2026
Figure 14. Global Hemoperfusion Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Plasma Perfusion
Figure 16. Product Picture of Whole Blood Perfusion
Figure 17. Global Hemoperfusion Sales Market Share by Feature in 2026
Figure 18. Global Hemoperfusion Revenue Market Share by Feature (2021-2026)
Figure 19. Product Picture of Direct Selling
Figure 20. Product Picture of Distribution
Figure 21. Global Hemoperfusion Sales Market Share by Channel in 2026
Figure 22. Global Hemoperfusion Revenue Market Share by Channel (2021-2026)
Figure 23. Hemoperfusion Consumed in Hepatic Encephalopathy
Figure 24. Global Hemoperfusion Market: Hepatic Encephalopathy (2021-2026) & (K Units)
Figure 25. Hemoperfusion Consumed in Certain Autoimmune Diseases
Figure 26. Global Hemoperfusion Market: Certain Autoimmune Diseases (2021-2026) & (K Units)
Figure 27. Hemoperfusion Consumed in Drug Overdose
Figure 28. Global Hemoperfusion Market: Drug Overdose (2021-2026) & (K Units)
Figure 29. Hemoperfusion Consumed in Specific Intoxications
Figure 30. Global Hemoperfusion Market: Specific Intoxications (2021-2026) & (K Units)
Figure 31. Hemoperfusion Consumed in Others
Figure 32. Global Hemoperfusion Market: Others (2021-2026) & (K Units)
Figure 33. Global Hemoperfusion Sale Market Share by Application (2025)
Figure 34. Global Hemoperfusion Revenue Market Share by Application in 2026
Figure 35. Hemoperfusion Sales by Company in 2026 (K Units)
Figure 36. Global Hemoperfusion Sales Market Share by Company in 2026
Figure 37. Hemoperfusion Revenue by Company in 2026 ($ millions)
Figure 38. Global Hemoperfusion Revenue Market Share by Company in 2026
Figure 39. Global Hemoperfusion Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Hemoperfusion Revenue Market Share by Geographic Region in 2026
Figure 41. Americas Hemoperfusion Sales 2021-2026 (K Units)
Figure 42. Americas Hemoperfusion Revenue 2021-2026 ($ millions)
Figure 43. APAC Hemoperfusion Sales 2021-2026 (K Units)
Figure 44. APAC Hemoperfusion Revenue 2021-2026 ($ millions)
Figure 45. Europe Hemoperfusion Sales 2021-2026 (K Units)
Figure 46. Europe Hemoperfusion Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Hemoperfusion Sales 2021-2026 (K Units)
Figure 48. Middle East & Africa Hemoperfusion Revenue 2021-2026 ($ millions)
Figure 49. Americas Hemoperfusion Sales Market Share by Country in 2026
Figure 50. Americas Hemoperfusion Revenue Market Share by Country (2021-2026)
Figure 51. Americas Hemoperfusion Sales Market Share by Type (2021-2026)
Figure 52. Americas Hemoperfusion Sales Market Share by Application (2021-2026)
Figure 53. United States Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Hemoperfusion Sales Market Share by Region in 2026
Figure 58. APAC Hemoperfusion Revenue Market Share by Region (2021-2026)
Figure 59. APAC Hemoperfusion Sales Market Share by Type (2021-2026)
Figure 60. APAC Hemoperfusion Sales Market Share by Application (2021-2026)
Figure 61. China Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 65. India Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Hemoperfusion Sales Market Share by Country in 2026
Figure 69. Europe Hemoperfusion Revenue Market Share by Country (2021-2026)
Figure 70. Europe Hemoperfusion Sales Market Share by Type (2021-2026)
Figure 71. Europe Hemoperfusion Sales Market Share by Application (2021-2026)
Figure 72. Germany Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 73. France Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Hemoperfusion Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Hemoperfusion Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Hemoperfusion Sales Market Share by Application (2021-2026)
Figure 80. Egypt Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Hemoperfusion in 2026
Figure 86. Manufacturing Process Analysis of Hemoperfusion
Figure 87. Industry Chain Structure of Hemoperfusion
Figure 88. Channels of Distribution
Figure 89. Global Hemoperfusion Sales Market Forecast by Region (2027-2032)
Figure 90. Global Hemoperfusion Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Hemoperfusion Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Hemoperfusion Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Hemoperfusion Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Hemoperfusion Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Hemoperfusion
Figure 2. Hemoperfusion Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hemoperfusion Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Hemoperfusion Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Hemoperfusion Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Hemoperfusion Sales Market Share by Country/Region (2025)
Figure 10. Hemoperfusion Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Activated Carbon Adsorption
Figure 12. Product Picture of Resin Adsorption
Figure 13. Global Hemoperfusion Sales Market Share by Type in 2026
Figure 14. Global Hemoperfusion Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Plasma Perfusion
Figure 16. Product Picture of Whole Blood Perfusion
Figure 17. Global Hemoperfusion Sales Market Share by Feature in 2026
Figure 18. Global Hemoperfusion Revenue Market Share by Feature (2021-2026)
Figure 19. Product Picture of Direct Selling
Figure 20. Product Picture of Distribution
Figure 21. Global Hemoperfusion Sales Market Share by Channel in 2026
Figure 22. Global Hemoperfusion Revenue Market Share by Channel (2021-2026)
Figure 23. Hemoperfusion Consumed in Hepatic Encephalopathy
Figure 24. Global Hemoperfusion Market: Hepatic Encephalopathy (2021-2026) & (K Units)
Figure 25. Hemoperfusion Consumed in Certain Autoimmune Diseases
Figure 26. Global Hemoperfusion Market: Certain Autoimmune Diseases (2021-2026) & (K Units)
Figure 27. Hemoperfusion Consumed in Drug Overdose
Figure 28. Global Hemoperfusion Market: Drug Overdose (2021-2026) & (K Units)
Figure 29. Hemoperfusion Consumed in Specific Intoxications
Figure 30. Global Hemoperfusion Market: Specific Intoxications (2021-2026) & (K Units)
Figure 31. Hemoperfusion Consumed in Others
Figure 32. Global Hemoperfusion Market: Others (2021-2026) & (K Units)
Figure 33. Global Hemoperfusion Sale Market Share by Application (2025)
Figure 34. Global Hemoperfusion Revenue Market Share by Application in 2026
Figure 35. Hemoperfusion Sales by Company in 2026 (K Units)
Figure 36. Global Hemoperfusion Sales Market Share by Company in 2026
Figure 37. Hemoperfusion Revenue by Company in 2026 ($ millions)
Figure 38. Global Hemoperfusion Revenue Market Share by Company in 2026
Figure 39. Global Hemoperfusion Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Hemoperfusion Revenue Market Share by Geographic Region in 2026
Figure 41. Americas Hemoperfusion Sales 2021-2026 (K Units)
Figure 42. Americas Hemoperfusion Revenue 2021-2026 ($ millions)
Figure 43. APAC Hemoperfusion Sales 2021-2026 (K Units)
Figure 44. APAC Hemoperfusion Revenue 2021-2026 ($ millions)
Figure 45. Europe Hemoperfusion Sales 2021-2026 (K Units)
Figure 46. Europe Hemoperfusion Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Hemoperfusion Sales 2021-2026 (K Units)
Figure 48. Middle East & Africa Hemoperfusion Revenue 2021-2026 ($ millions)
Figure 49. Americas Hemoperfusion Sales Market Share by Country in 2026
Figure 50. Americas Hemoperfusion Revenue Market Share by Country (2021-2026)
Figure 51. Americas Hemoperfusion Sales Market Share by Type (2021-2026)
Figure 52. Americas Hemoperfusion Sales Market Share by Application (2021-2026)
Figure 53. United States Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Hemoperfusion Sales Market Share by Region in 2026
Figure 58. APAC Hemoperfusion Revenue Market Share by Region (2021-2026)
Figure 59. APAC Hemoperfusion Sales Market Share by Type (2021-2026)
Figure 60. APAC Hemoperfusion Sales Market Share by Application (2021-2026)
Figure 61. China Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 65. India Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Hemoperfusion Sales Market Share by Country in 2026
Figure 69. Europe Hemoperfusion Revenue Market Share by Country (2021-2026)
Figure 70. Europe Hemoperfusion Sales Market Share by Type (2021-2026)
Figure 71. Europe Hemoperfusion Sales Market Share by Application (2021-2026)
Figure 72. Germany Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 73. France Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Hemoperfusion Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Hemoperfusion Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Hemoperfusion Sales Market Share by Application (2021-2026)
Figure 80. Egypt Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Hemoperfusion in 2026
Figure 86. Manufacturing Process Analysis of Hemoperfusion
Figure 87. Industry Chain Structure of Hemoperfusion
Figure 88. Channels of Distribution
Figure 89. Global Hemoperfusion Sales Market Forecast by Region (2027-2032)
Figure 90. Global Hemoperfusion Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Hemoperfusion Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Hemoperfusion Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Hemoperfusion Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Hemoperfusion Revenue Market Share Forecast by Application (2027-2032)
More Publications
Global Medical Tapes Market Growth 2025-2031
US$ 3,660.00
December 2024
166 pages
Global Dental Scalers Market Growth 2023-2029
US$ 3,660.00
March 2023
108 pages
Global Pressure Mode Neonatal Ventilators Market Growth 2024-2030
US$ 3,660.00
March 2024
130 pages
